We review the role of classical complement activation in kidney transplantation.
We discuss the role of C4d staining as a marker of antibody-mediated rejection.
Bead arrays enable in vitro detection of alloantibody-triggered complement deposition.
In vitro complement binding assays may help uncover harmful HLA alloreactivity.